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People living in the tropical and subtropical regions of the world face an enormous health burden due to mosquito-borne diseases
such as malaria, dengue fever, and filariasis. Historically and today, targeting mosquito vectors with, primarily, insecticide-based
control strategies have been a key control strategy against major mosquito-borne diseases. However, the success to date of such
approaches is under threat frommultiple insecticide resistance mechanisms while vector control (VC) options are still limited.The
situation therefore requires the development of innovative controlmeasures against majormosquito-borne diseases. Transinfecting
mosquitos with symbiotic bacteria that can compete with targeted pathogens or manipulate host biology to reduce their vectorial
capacity are a promising and innovative biological control approach. In this review, we discuss the current state of knowledge about
the association between mosquitoes and Wolbachia, emphasizing the limitations of different mosquito control strategies and the
use of mosquitoes’ commensal microbiota as innovative approaches to control mosquito-borne diseases.
1. Introduction
Mosquitoes of theAnopheles,Aedes, andCulex genera include
a number of main vector species of protozoan, virus, and
nematode pathogens [1]. Therefore, since their first associa-
tion with the transmission of such pathogens to humans and
other vertebrates in the late nineteenth century [1], targeting
mosquito vectors to interrupt the transmission of diseases
has been a key control strategy againstmajormosquito-borne
diseases such as malaria, yellow fever, dengue, chikungunya
fever, and Zika virus infection. During the first quarter
of the twentieth century, mosquito control activities were
primarily based on source reduction, through larviciding
using petroleum oils and larvivorous fish, together with
environmental-based management [2]. With the advent of
Dichlorodiphenyltrichloroethane (DDT) and the discovery
of its insecticidal properties in the early 1940s, began the
chemical era of vector control (VC) with mainly DDT-
based interventions, both as larvicide and adulticide [3].
The publication of “Silent Spring” by Rachel Carson in 1962
raised public concerns about the use of DDT, characterized
by high mammalian toxicity, poisoning risks to nontarget
organisms, persistence in the biosphere surface, and an
accumulation in food-chains [2]. Increasing public concerns
about Persistent Organic Pollutants (POPs) led to DDT being
banned. Fortunately, in the 1980s, a few years before the
prohibition of DDT, synthetic pyrethroids compounds were
added to the arsenal of public health insecticides [4]. Between
2000 and 2015, pyrethroid-treated bed-nets (ITNs), indoor
residual spraying (IRS) with residual insecticides, and other
insecticide-based strategies were widely used as front-line
tools against the vectors ofmalaria and othermosquito-borne
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diseases [5] in an Integrated Vector Management (IVM)
framework [3]. However, despite controversial, growing mul-
tiple insecticide resistance mechanisms threaten to reverse
the progresses made so far to eliminate or control main
mosquito-borne diseases [1, 6]. In this context, attention has
turned toward research onto biological control, transgenic
and paratransgenic approaches as potential alternatives, or
complements to current chemical strategies [7].
Mosquito transgenesis is based on genetic modifications
to introduce novel elements into the mosquito genomes.
According to Abraham et al. [8], the two major transgenic
approaches are (i) the genetic suppression or limitation of
the vectors’ ability to serve as competent hosts for parasite
development, thus decreasing or eliminating their ability
to transmit pathogens (vector competence), and (ii) the
genetic suppression of insect populations by reducing the
lifespans of known vectors.These approaches can, potentially,
be used to control mosquito populations by reducing their
ability to transmit human or animal pathogens [9]. For
instance, Anopheles gambiae and Anopheles stephensi, the
respectivemainmalarial vectors inAfrica andAsia, have been
successfully engineered to interfere with malaria parasites, to
stop or at least reduce transmission of the disease [10, 11].
Nowadays, there is a huge potential for transgenic vector
control strategies. However, genetic manipulation tends to
reduce the fitness of the modified mosquitoes thus reducing
the chance of successfully spreading of genes of interest
among natural populations of the targeted vector species [12].
Moreover, failure of spreading transgenes (Weill M. personal
communication), mutation, and recombination rates could
seriously undermine the feasibility or durability of such
an approach as anticipated for the engineered geminivirus
aiming to protect crops in the agricultural sector [5].
The recent discovery of a number of symbiotic bacteria
inhabiting the gut and/or reproductive tissues of arthropods
has opened the way for innovative control strategies against
some of the major vector-borne diseases [13, 14]. Indeed,
bacterial symbionts associated with mosquitoes can directly
exert a pathogenic effect on their host [15], interfere with
its reproduction [16, 17], and reduce vector competence [18].
Furthermore, the use of genetically modified bacteria to
deliver antiparasite molecules has several advantages over
the use of genetically modified vectors [19]. Strategies to
exploit symbiotic microorganisms to control vector-borne
diseases are known as paratransgenesis, i.e., the generation of
engineered symbionts expressing antiparasite molecules [20].
Moreover, organisms that are able to manipulate their host
biology and even shorten their lifespan may be of the highest
interest for use as biological control agents.
Over the last decade, the focus has been put upon
symbiotic microorganisms to identify potential candidates
which could be used in new vector control approaches.
Among the most promising candidates, several strains of
the genus Wolbachia, a dominant endosymbiotic bacterium
of numerous insects including major vectors of zoonotic
pathogens, are of highest interest for the scientific commu-
nity. Indeed, Wolbachia is a maternally inherited that can
infect mosquitoes’ reproductive organs to self-sustain itself
in host populations, but also somatic tissues where pathogens
Table 1: Taxonomic classification of Wolbachia.
Taxa Names
Domain Bacteria
Phylum Proteobacteria
Class Alphaproteobacteria
Subclass Rickettsidae
Order Rickettsiales
Family Rickettsiaceae
Genus Wolbachia
Type species Wolbachia pipientis, Hertig 1936
development occurs and compete with them. It is, therefore,
an interesting biological control agent which can be used
to stop or prevent the transmission of several vertebrate
pathogens to humans and domestic animals [21].
In this review, we discuss the current state of knowledge
about the association between mosquitoes and Wolbachia,
emphasizing the limitation of different mosquito control
strategies and the use of mosquitoes’ commensal microbiota
as innovative approaches to controlmosquito-borne diseases.
2. Methodology
2.1. SearchMethods. Peer-reviewed literature searchwas con-
ducted using online databases including PubMed, Bibliovie,
INSERM databases, Web of Knowledge, and Google Scholar
for articles. Gray literature searches were conducted using
World Health Organization (WHO)webpage.The key search
terms used was different combinations of “mosquito”, “wol-
bachia”, “biological control”, “control”, and “mosquito-borne
diseases” using theBoolean operator “OR”, and combinations
between concepts used the logical “AND”.
2.2. Data Screening. All documents were quickly checked to
assess their relevance to the project using information in the
title and the abstract. A subset of all relevant documents was
selected, sorted by section, further reviewed and compiled in
the manuscript.
3. Main Text
3.1. The Genus of Wolbachia (Alphaproteobacteria)
3.1.1. Description, Classification and Phylogeny. Bacteria of
the genusWolbachia are obligate intracellular Gram-negative
bacteria belonging to the Alphaproteobacteria class (Table 1)
found into the cytoplasmic vacuoles inside the cells of their
insects, isopods, mites, arachnids and nematodes hosts [22].
The genus was first discovered in 1924 byMarshall Hertig and
S. Burt Wolbach in the reproductive organs of Culex pipiens
[23], then subsequently described by Hertig in 1936, who
named the genus after his collaborator [24].
Wolbachia pipientis is the unique valid species of the
genus.Noteworthily, the twoother species that have been pre-
viously described as belonging to the genus Wolbachia [25]:
Wolbachia melophagi and Wolbachia persica were removed
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Figure 1: Electron microscopy of Wolbachia. (a) Wolbachia cocci (Scale bar: 1 𝜇m). (b) Zoom of two Wolbachia cells (Scale bar: 500 nm).
(c) Zoom of a singleWolbachia cell (Scale bar: 100 nm). (by El Hadji Amadou Niang).
latter on [26]. W. melophagi is now considered as nomen
nudum, because no strain of this species has been found
to date. While W. persica, which was isolated from the soft
tick Argas persicus, was erroneously attributed to the genus
as revealed by phylogenetic analysis of the 16S rRNA gene
showing its close relatedness to the genus Francisella [27].
Morphologically, Wolbachia is a pleomorphic bacterium
(Figure 1) that appears as small rods [0.5–1.3 𝜇l in length] and
coccoid forms [0.25–1 𝜇l]; large forms [1–1.8𝜇l in diameter]
growing inside vacuoles in the cytoplasm of host cells [28].
Despite its Gram-negative cell wall structure, Wolbachia is
poorly stained by Gram staining, but can be well visualized
using the Diff-Quik and May-Grunwald-Giemsa staining
methods.Using theGimenez stain, they can also be visualized
as dark-blue structures within a blue-green cytoplasm [29].
Since they do not form morulae and exclusively infect
arthropods and filarial nematodes, Wolbachia are easily
differentiated from other closely related genera [28].
Phylogenetic analysis of the 16S rRNA gene (Figure 2),
showed that W. pipientis, the nomen of the genus, forms
a monophyletic clade within the Alphaproteobacteria class,
closely related to the Anaplasma, Ehrlichia and Neorickettsia
genera of the Anaplasmataceae family [28].
Further analysis based on the 16S rRNA and the Wol-
bachia Surface Protein (wsp) genes, were used to cluster
the species into finer taxonomic scales. A system based on
the level of similarity in the wsp gene sequences has been
proposed for strain grouping. So far, 16 main evolutionary
lineages from different host taxa known as “supergroups”
have been identified and designated by the letters A toQ, with
the exception of G [22].The usefulness of such an assemblage
remains controversial and the suggestion of splitting W.
pipientis into multiple species has its pros and cons [32, 33].
Typically, the supergroups A and B are widely spread
acrossmany arthropod taxa [34].Their common ancestor has
probably diverged approximately 58–67 million years ago, at
a time when all modern Arthropoda orders already existed
[22]. The supergroups C and D are obligate and beneficial
endosymbionts in somefilarial nematodes [34–37].While the
F supergroup is peculiar and includes both nematode and
arthropodWolbachia strains [37–40].More specific to certain
host lineages, strains in supergroup E have been reported
from Collembola [41, 42], in H from termites [40], and in M
and N from aphids [43]. Further distinct supergroups have
been identified either in nematodes or arthropods [34].
3.1.2. Obligate Intracellular Lifestyle. A range of microbial
pathogens interact with their host in numerous and complex
ways. Many are extracellular, while others invade organs and
multiply within specific vector cells [44].Wolbachia belongs
to the latter group and has an original lifestyle as an obligate
intracellular symbiont (endosymbiont) in close relationship
with infected eukaryotic cells [45]. In arthropods,Wolbachia
grow inside vacuoles often within the cytoplasm in the
host’s reproductive cells. However, they can also be found in
somatic tissues, including nervous tissue and hemocytes [28].
Growing research has provided exciting insights into various
aspects of theWolbachia’s biology [46]. One of the most obvi-
ous consequences of their presence inside reproductive cells
is the facilitation of their transovarian transmission to their
host’s offspring. Analysis of the sequenced genomes of several
members of the a-Proteobacteria group, to which belong the
Wolbachia genus, has also provided greater understanding of
their reductive genome evolution and antigenic variation as
well as how they manipulate host cells [44]. However, the
intracellular lifestyle has led to the loss of several genes as
a consequence of the reduced genome size, varying from 1.1
Mb to 1.5 Mb, including less than 1000 protein-coding genes
[45]. Furthermore, it has been reported that intracellular
symbionts, such as Wolbachia, transfer genes into the host
nucleus and vice versa [47, 48]. Leclercq et al. [49] showed
high affinity between coding sequences of the f-element of the
common pillbug (Armadillidium vulgare) with a large piece
of the genome of the feminizing wVulC Wolbachia strain.
Symbionts may also acquire genes fromother symbionts [47].
The high level of genetic exchange in Wolbachia mentioned
above suggests that its core genome is completed by an
extensive auxiliary genome. As explained by Ishmael et al.
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Figure 2:Molecular Phylogenetic analysis of Anaplasmataceae by Maximum Likelihood method.The evolutionary history was inferred
using theMaximumLikelihoodmethod based on the Tamura-Neimodel [30].The tree with the highest log likelihood (-4338.5700) is shown.
Thepercentage of trees inwhich the associated taxa clustered together is shownnext to the branches. Initial tree(s) for the heuristic searchwere
obtained automatically by applying the Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using the Maximum
Composite Likelihood (MCL) approach, and then selecting the topology with the higher log likelihood value. The analysis involved five
nucleotide sequences. All positions containing gaps and missing data were eliminated.There was a total of 1,411 positions in the final dataset.
Evolutionary analyses were conducted in MEGA7 [31].
[50], the core genome contains all the housekeeping genes
shared by all (or almost all) sequenced strains for a given
taxon, while all other genes constitute the auxiliary genome,
encompassing the genetic variation within the species.
3.1.3. Host Reproductive Manipulation. Wolbachia are typ-
ically transmitted vertically through host eggs and alter
host biology in diverse ways. They induce reproductive
manipulations (Figure 3), such as (i) the feminization of
infected males (i.e., turning genetic males into females); (ii)
induced parthenogenesis (i.e., reproduction without males);
(iii) killing of infected males; and (iv) cytoplasmic incom-
patibility (i.e., modification of sperm from infected males
resulting in embryonic defects and death) [34, 51].
(1) Feminization. Infected males are “dead ends” for Wol-
bachia inheritance, because they do not transmit Wolbachia
infection to their offspring. Thus, converting infected male
offspring into females increases the potential for Wolbachia
to be transmitted to the next generation. The phenomenon
was first described in isopods such as Armadillidium vulgare
and more recently in insects [52], where it involves different
mechanisms, operating at the embryonic stage [51, 52]. In sev-
eral species of terrestrial isopod within the order Oniscidae,
Wolbachia invade the androgenic gland. The hypertrophied
gland is then inhibited, causing genetic males to develop as
females [53]. Among insects, feminizing strains have been
reported in Ostrinia furnacalis (Lepidoptera) and in Eurema
hecabe (Lepidoptera) and Zyginidia pullula (Hemiptera), in
which the involved mechanisms remain unclear [51].
(2) Parthenogenesis. Another beneficial strategy to increase
the maternal inheritance of Wolbachia is to induce the
production of female offspringwithout fertilization by sperm,
a process known as parthenogenesis (thelytoky). Wolbachia-
induced female parthenogenesis is less common and has
only been documented in haplodiploid species such as thrips
(Thysanoptera), mites (Acari) and wasps (Hymenoptera) [51].
In these organisms, males normally develop from unfertil-
ized haploid eggs (arrhenotokous parthenogenesis), whereas
females develop from fertilized diploid eggs. Wolbachia
disrupt the cells’ early embryonic development, doubling the
number of chromosomes in the unfertilized haploid eggs
and rendering them diploid. This leads to development as an
asexually produced female, so that infected females produce
twice as many daughters as uninfected ones, allowing their
cytoplasm to be transmitted to twice asmany granddaughters
as possible [54].
(3) Male Killing. In Coleoptera, Lepidoptera, Diptera (Insecta)
and Pseudoscorpiones (Arachnida), Wolbachia induce male
killing of infected females’ male progeny. This phenotype,
occurring mainly during embryogenesis, provides fitness
benefits to the female progeny in terms of the competi-
tion for resources. -induced male killing occurs through
lethal feminization. Indeed, when Insight into the mech-
anism has shown that Wolbachia infected mothers were
treated with tetracycline to removeWolbachia, genetic males
survive, whereas in the presence of Wolbachia, genetic
males become feminized and die during larval development
[51, 54].
(4) Cytoplasmic Incompatibility (CI). Wolbachia-induced
cytoplasmic incompatibility (CI) is the most commonly
described reproductive manipulation phenotype. Reproduc-
tive incompatibility between populations of the Culex pipiens
mosquito was first reported in the 1950s, but Wolbachia was
only identified as the causative agent in the 1970s [55]. This
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Figure 3: Different phenotypes ofWolbachia’s host reproductive manipulation.
phenotype comprises two distinct components: Wolbachia-
induced modification of sperm during spermatogenesis and
rescue of this modification in embryos infected with the same
strain [51]. The incompatible cross, due to the asynchrony
of the male and female pronuclei phases at the initial stage
of mitosis, occurs when Wolbachia-infected males mate
with uninfected females (unidirectional CI). Bidirectional
CI occurs when both partners are infected by different but
incompatible Wolbachia strains, causing cross lethality in
both directions. CI has been widely described in numerous
arthropod host species infected byWolbachia strains belong-
ing to both the A and B supergroups [56].
3.1.4. Wolbachia spp. and Insects. The “pandemic” nature of
Wolbachia [46] resulting in their widespread distribution in
various invertebrate hosts (Figure 4) is explained by their
ability to manipulate host reproduction, but also by their
ability to move horizontally across species boundaries [51,
54]. It has been estimated that different strains of Wolbachia
may infect more than 65% of insect species [34]. Among
these, several mosquito species belonging to different genera
have been found carrying different strains.
3.2. Mosquitoes (Diptera, Culicidae)
3.2.1. Taxonomy, Classification and Phylogeny. Mosquitoes
are a monophyletic group that belongs to the order ofDiptera
(Table 2 and Figure 5) [58]. The origin and phylogenetic his-
tory of the family ofCulicidaedates back to theMesozoic Era.
It is estimated that the main lineages of current mosquitoes
date from the early Cretaceous period (145-100million years)
[58, 59].
The family of Culicidae is a large and abundant group
which is distributed from tropical latitudes to temperate
regions, well beyond the Arctic Circle. It includes approx-
imately 4,000 species, classified into two subfamilies and
112 genera. The subfamily Anophelinae has three genera and
Culicinae has 109 genera, segregated into 11 tribes [58].
Mosquitoes are of prime medical and veterinary impor-
tance. In nearly all Culicidae species, only females feed on
vertebrates, because of their need for blood to produce
their offspring. During blood-sucking, a complex salivary
Table 2: Taxonomic classification of mosquitoes (Diptera: Culici-
dae).
Taxa Names
Kingdom Animalia
Phylum Arthropoda
Class Insecta
Order Diptera
Suborder Nematocera
Infraorder Culicomorpha
Superfamily Culicoidea
Family CulicidaeMeigen, 1818
Sub-families Anophelinae, Culicinae
Genera (112) Culex, Aedes, Anopheles, etc.
secretion facilitates feeding but also enables several pathogens
(viruses, protozoa, and nematode worms) to be directly
injected into the capillaries of their vertebrate hosts [60].
3.2.2. Mosquitoes of Medical and Veterinary Importance.
Mosquito-borne diseases such as malaria, filariases, dengue,
chikungunya, Zika, andWest Nile fevers represent significant
medical and veterinary problems around the world and lead
to major economic problems [61]. Table 3 summarises some
of the most devastating mosquito-borne diseases [59].
3.2.3. Wolbachia andMosquitoes. Among Culicidae, two types
of Wolbachia infections can be distinguished: natural Wol-
bachia infections and transinfected mosquito lines.
(1) NaturalWolbachia Infections.The interest in theWolbachia
genus has renewed when the biological connection between
cytoplasmic incompatibility and Wolbachia infection was
established and documented by Yen & Barr [55] in the early
1970s. Subsequently, Yen [62] reported the presence of Wol-
bachia within the ovaries and eggs of mosquito members of
the Aedes scutellaris group (Aedes cooki, Aedes polynesiensis,
Aedes albopictus, and Aedes riversi). In 2002, while screening
several mosquitoes species, Ricci et al. [63] found arthropod
strains of Wolbachia in Culex modestus, Culex pipiens, and
Coquillettidia richiardii, while three other mosquitoes (Aedes
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Figure 4: Wolbachia in arthropods. (Modified from Russell & Steiner 2012, Myrmecological News Journal [57]). (a) Graph illustrating
Wolbachia-infected (Blue shaded portion) andWolbachia-uninfected (white portion) proportions by host taxon. (b) Histogram highlighting
the frequenciesWolbachia infection of some dipteral families. The asterisk (∗) indicates the recent discovery of nativeWolbachia within the
Anopheles genus.
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Figure 5: Classiﬁcation of mosquitoes (DIPTERA: CULICIDAE) (by El Hadji Amadou Niang).
cinereus, Aedes detritus, and Ae. geniculatus) were infected
with filarial strains previously described from Dirofilaria
immitis, and two mosquitoes (Aedes punctor and Culex tor-
rentium) were positive for both arthropod and filarial strains.
Later, the development of PCR and sequencing techniques
has led to the discovery of many otherWolbachia strains from
several other mosquito species.
A recent meta-analysis of the distribution ofWolbachia in
mosquitoes indicated that, of 185 mosquito screened, 31.4%
was Wolbachia-infected but also demonstrated the nonran-
dom distribution of Wolbachia among different mosquito
taxa [64]. Indeed, Wolbachia was found in 39.5% of the 147
mosquito species screened, but never in Ae. aegypti, the
primary vector of Dengue, Chikungunya, and Zika viruses
[9, 64]. Moreover, prior to 2014 no Wolbachia infection
has been documented in 38 anopheline species, including
several important malarial vector species (An. gambiae, An.
arabiensis, An. funestus, An. stephensi, An. culicifacies, An.
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Table 3: Main diseases transmitted by mosquito.
Diseases Pathogens Genera of main vectors Vertebrate hosts Reservoir hosts
Yellow fever Yellow Fever virus(Flavivirus) Aedes Haemagogus Sabethes Humans Monkeys
Dengue fever
Dengue (D1, D2, D3, D4)
viruses
(Flavivirus)
Aedes Humans Monkeys
Chikungunya Chikungunya virus(Alphavirus) Aedes Humans Monkeys
Zika fever Zika virus (ZIKV)(Flavivirus) Aedes Humans Monkeys
Ri Valley fever Rift Valley fever virus(Phlebovirus) Aedes, Culex Sheep, Goats, Humans Bats
West Nile Fever West Nile virus
(Flavivirus)
Culex Horses, Humans Birds
Equine Encephalitis Equine Encephalitis virus
(Alphavirus, Flavivirus)
Culex Horses Birds
Japanese Encephalitis Japanese Encephalitis virus
(Flavivirus)
Culex Horses, Humans Pigs and wild birds
Saint Louis Encephalitis
Saint Louis Encephalitis
virus
(Flavivirus)
Culex Humans, Animals Birds
Malaria
P. falciparum, P. vivax, P.
malariae, P. ovale, P.
knowlesi
Anopheles Humans Monkeys for P. knowlesi
Lymphatic ﬁlariasis Wuchereria bancrofti,Brugia malaya Anopheles, Aedes, Culex Humans Wild mammals for B. malaya
dirus, An. Albimanus, and An. darlingi), which has led to
the previous believe that Wolbachia were unable to infect
Anopheles species until their very recent discovery in natural
populations of Anopheles gambiae and Anopheles coluzzii
in Burkina Faso [21, 65] and in Mali (Gomes et al. 2017).
More recently Ayala et al. [66] and Jeffries et al. [67] have
revealed that native Wolbachia infections was wider than
expected among natural anopheline populations with at least
16 species naturally infected (Table 4). Furthermore, Ayala
et al. [66] revealed a large diversity of Wolbachia strains
in wild anopheline populations, which offers an unexpected
opportunity to discover suitable phenotypes to suppress
Plasmodium transmission and/or to manipulate Anopheles
reproduction and reduces the malaria burden in Africa [66].
(2) Mosquito Transinfection. The absence of natural infection
in some dominant vector species has been a limiting factor
for the potential operational use of Wolbachia to control
vectors and the diseases they transmit. The ability of the
bacterium to adapt to new intracellular environments has
been exploited to transinfect vector species of medical and
veterinary importance [9]. Transinfection via embryonic
microinjection was used to transfer severalWolbachia strains
into Ae. albopictus [64] and Ae. aegypti. For instance, the
life-shortening strain of Wolbachia (wMelPop-CLA) from
Drosophila melanogaster was successfully and stably intro-
duced into Ae. aegypti to reduce its life-span. Given the proof
that wMelPop strain being protective against RNA viruses
in Drosophila, its derivate has been used latter to block
Dengue, Chikungunya transmitted by Ae. aegypti, while the
wMelWolbachia strain (wMel Br) has been used successfully
against Zika infections in Brazil [69, 70]. Contrary to the
complex Wolbachia-Arbovirus vectors, current views about
the impact ofWolbachia onPlasmodium infections are almost
entirely based on artificially transfected mosquito models
[71]. In the Anophelinae sub-family,Wolbachia transinfection
has been successful in Anopheles gambiae [72, 73] and in
Anopheles stephensi [74], respectively major vectors of human
malaria in Africa and the Middle East, and South Asia [75,
76].
3.2.4. Vector Control Approaches for the Control of Mosquito-
Borne Diseases. In the past century, significant advances
have been made in controlling main vector-borne diseases.
Malaria disappeared from the northern hemisphere, diseases
such as typhus, Bartonella, and yellow fever prevalence
were drastically reduced in many countries with effective
vector control methods [9]. Despite these successes, there
are currently no effective vaccines against dengue, filariasis,
or malaria, and specific treatments are only available for
malaria and some filariases. Historically and today, targeting
mosquito vectors has been a key control strategy against
major mosquito-borne diseases. Vector control is an essential
component of mosquito-borne disease prevention and con-
trol. Its aim is to interrupt or eliminate local transmission or
reduce vulnerability to disease and prevent secondary infec-
tions from introduced diseases and prevent outbreaks. Before
the Second World War, vector control was predominantly
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based on the environmental control of the proliferation of
mosquitoes [3]. The so-called “chemical period” then began
with the advent of DDT and other organochlorine pesticides
in the late 1940s. During this period, widescale spraying of
the indoor surfaces of houses and shelters drastically reduced
the number of malarial mosquitoes and other insects and led
to the successful eradication of malaria in the United States,
European countries, the Soviet Union, South East Asia, India,
and South America [4, 77]. But the Malaria Eradication Pro-
gramme failed in several malarial pilot areas in the African
continent, due to the extremely high malaria heterogeneity
and vector behavioral plasticity [78]. However, during the
past decade there has been a global renewed focus on vector
control with the widespread use of impregnated (LLINs) and
sprayed materials (IRS), particularly against malaria vectors.
Large community-based distribution and/or IRS campaigns
have led to significant ITN and IRS coverage in several
African countries, resulting in a substantial drop in the preva-
lence of malaria in that region [3]. However, to make vector
control more effective, cost effective, ecologically sound, and
sustainable the WHO adopted in 2004 the Global Strategic
Framework on Integrated Vector Management (IVM) as the
first step towards the search and the implementation of new
approaches to control vectors and the diseases they transmit
[3]. Defined as “a rational decision-making process for the
optimal use of resources for vector control,” IVM is not a new
concept since its basic principles have been used over the past
century in the USA through the vast network of Mosquito
Abatement Districts implemented to protect people from
nuisance-biting and vector species of mosquitoes [79]. Lately,
the WHO called for the strengthening of IVM as one of the
strategic areas for action in the global plan framework to
combat neglected tropical diseases for 2008–2015.
Although insecticides have been successful in controlling
vectors, current ecological and environmental protection
standards make insecticide-based strategies unsustainable,
due to the adverse effects of many insecticides on nontarget
species, their environmental impact, the contamination of
soil andwater and the development of selective processes, and
subsequent mosquito resistance to insecticides [1]. Moreover,
a number of malaria prevention and control tools currently
available are quite expensive, while arbovirus vector man-
agement also has to face significant challenges, due to the
peculiar traits ofAedes vectors, which have huge physiological
and ecological plasticitymaking themdifficult to control [80].
A broad spectrum of resistance to insecticides has evolved
in the Culex genus, involving both “Metabolic” (enhanced
esterase, glutathione-S-transferase, or p450 monooxygenase
activities) and “Target Site” (modification of the acetyl-
cholinesterase; the GABA receptors; or the sodium channels)
mechanisms [81]. There is, therefore, an urgent need for
effective alternative vector control strategies that can be used
on a large scale and which are environmentally friendly. This
is critical to sustaining control efforts and to achieving the
goal of malaria elimination. Potential alternatives or com-
plementary strategies to current core interventions include
genetic control approaches, using refractory mosquitoes to
replace vector populations or the release of mosquitoes
carrying a lethal gene to suppress the targeted populations
[1]. In addition to transgenic mosquitoes, paratransgenic and
biological control approaches provide concrete possibilities
for innovative vector control strategies [7].
3.2.5. Biological Control of Mosquito-Borne Diseases. Beyond
the paratransgenic VC approaches taking advantage of the
naturally/transinfected mosquitoes microbiota and defined
as the use of symbiotic organisms naturally inhabit or
successfully introduced into mosquitoes to deliver an effector
molecule to inhibit, compete or kill the pathogen in insects
[1, 9], their utilisation to directly interfere with or modulate
vector immunity against pathogens constitutes a Biological
approach to control MBD. The feasibility of the paratrans-
genic approach was demonstrated by Durvasula et al. [82],
when they successfully transformed a commensal symbiont
in the hindgut lumen of Rhodnius prolixus, Rhodococcus
rhodnii, to express the cecropin A protein to kill the causative
agent of Chagas disease, and Trypanosoma cruzi inside their
host. Similarly, the recent use of the life-shorteningWolbachia
wMelPop-CLA strain is a prelude for an innovative Biological
approach to control MBD. Indeed, intracellular bacteria such
as Wolbachia that can manipulate their host biology, includ-
ing their immune system, are unduly regarded as promising
innovative biocontrol approach to control insect-transmitted
diseases. Therefore, several studies have attempted to show
the potential for Wolbachia to be used in such a strategy
to control mosquito-transmitted diseases [74]. Wolbachia
has several characteristics, including the capacity to perturb
insect ecology, behaviour, and physiology, making it one
of the best candidates for blocking, or at least significantly
reducing, the transmission of pathogens of medical and
veterinary importance [21]. However, before the operational
implementation of anyWolbachia-based approach, an impor-
tant prerequisite is to better characterize all potential the
strain of the genus and their host manipulation phenotypes
which could make them good biocontrol agents candidates,
to develop predictive models, and to perform a compre-
hensive risk assessment for their use to control mosquitoes
and disease they transmit. As stated before, Wolbachia-
transinfection technology has already shown promise in con-
trolling the transmission of arboviruses by Ae. aegypti using
different Wolbachia strains which can shorten vector lifes-
pans, limit susceptibility to infection, and induce cytoplasmic
incompatibility to reduce vector density. Furthermore, in An.
gambiae andAn. stephensi, the presence ofWolbachia appears
to negatively impact the Plasmodium developmental cycle
and egg laying [21, 74, 83]. Although potentially eligible as
an inovative weapon, our knowledge ofWolbachia-mediated
antiparasite mechanisms is fragmented, if not completely
lacking. A significant delay in the virus-induced mortality
of the pathogenic Drosophila C, Cricket paralysis and Flock
House virus have been related to the presence of Wolbachia
in the host. Johnson hypothesized that by reducing the
viral load Wolbachia endosymbionts enhance host survival
[84]. However, since different Wolbachia strains affect a
wide variety of insect viruses this likely suggests that the
underlying mechanisms are not pathogen specific/Wolbachia
interactions but involve putatively broad processes targeting a
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wide-range of viral types, including competition for resources
and the upregulation of hosts’ immune responses.
(1) Wolbachia-Based Approach to Control Arboviruses Dis-
eases. A new era for controlling arboviruses started with
the successful introduction of the life-shortening wMelPop-
CLA Wolbachia strain into Ae. aegypti to reduce its natural
populations life span [85, 86]. Primary data gathered from
field trials in Australia has made it possible to validate
theoretical models for Wolbachia population dynamics and
has demonstrated the feasibility and sustainability of such
a strategy to control mosquito populations and the diseases
they transmit [87]. However, barriers to dispersal respon-
sible for a slower than anticipated spread of transinfected
Aedes aegypti mosquito in Cairns (Australia) [88] should
be taken into account in future releases. Moreover, how
Wolbachia strains of interest interfere with pathogens is a
critical aspect that needs to be better understood when
dealing with Wolbachia-based approaches. Several authors
have attempted to unravel the basis of Wolbachia pathogen
blocking. To that aim, Terradas and McGraw discussed the
possible mechanistic basis of Wolbachia-mediated pathogen
blocking and have evaluated the existence of evidences
from field mosquitoes and related insects [89]. They showed
that the amount of Wolbachia inside host cells and tissues
appears to correlate with the strength ofWolbachia-mediated
blocking. They revealed that the highly replicative Wolbachia
strain (wMelPop) by exhibiting great cellular loads causes
tissue damage thus inducing near perfect blocking in Ae.
aegypti [89]. Another possible mode of action through which
Wolbachia interferes with pathogen infection is by priming
the host immune system, with the preactivation of the
immune response which could then theoretically protect the
insect from a range of pathogens. Gene regulation is another
way by whichWolbachiamodulates the host immune system
as demonstrated by recent studies about the potential role of
the Vago protein on the innate immune pathways of Culex
quinquefasciatus and Ae. aegypti to restrict West Nile and
dengue virus replication [90]. For instance, Asad et al. have
shown that in Wolbachia-infected cells, knocking-down the
Vago1 gene led to significant increases in DENV replication
with no effect on Wolbachia density, and concluded that in
Ae. aegypti the induction of the AeVago1 protein, mediated
byWolbachia in infected cells, may function as a host factor
to suppress DENV replication [90].
(2) Wolbachia-Based Approach to Control Malaria. As re-
ported in the last World Malaria Report 2017, despite sig-
nificant progress made since 2000, the rate of decline of
malaria has stalled and even reversed in some region since
2014 [91]. Reasons for this are the spread of resistance of
parasite to antimalarial drugs and vectors to insecticides
[4]. Beside the implementation of a strategic insecticide
resistance monitoring for malaria endemic countries, the
WHO’s Global plan for insecticide resistance management in
malaria vectors (GPIRM) highlighted also the need for the
development of innovative approaches for sustainable vector
control at global scale [92]. As a response to that, attention
has been drawn tomosquitoes’ microbiota and their potential
impact on host fitness and parasite evolution [93].Wolbachia-
mediated parasite interference in other insect systems has
raised the exciting possibility of using them to control or
limit the spread of malaria. However, the development of
Wolbachia-based antimalarial strategies has been impeded by
the lack of stable Wolbachia infections in natural anopheline
populations, as well as the failure to establish stable inherited
transinfections in anopheline mosquitoes. Both issues have
recently been overcome with the successful establishment
of a stable Wolbachia strain wAlbB infection in Anopheles
stephensi, an important malarial vector in Asia [74], and the
recent report of stable Wolbachia infections in natural popu-
lations of two important malarial vectors, Anopheles gambiae
and Anopheles coluzzii, in Burkina Faso [65]. Furthermore,
Shaw et al. showed that the wAnga strain stably infects
reproductive tissues (ovaries), and certainly somatic tissues
where thePlasmodiumdevelopment occurs, andwhere itmay
effectively compete for resources or upregulate the immune
response to effectively kill the malaria parasite [21]. Similar
results were reported recently in Mali with a new anopheline
Wolbachia strain (wAnga-Mali) [83]. Interestingly, experi-
mental infection showed that wAnga-Mali has strong impact
on late sporozoites stages and reduces malaria transmission
[83]. Both studies showed the potential for the release ofWol-
bachia-infected mosquitoes as a promising strategy to reduce
malaria transmission, but also raised the great limitation due
to the apparent lack of clear Cytoplasm Incompatibility [21]
to ensure released population self-sustenance in the nature.
The recent discovery of native Wolbachia infections in 16 out
of 25 wild African Anopheles species, including both vectors
and non-vectors of malaria confirm that natural Wolbachia
infection in anopheline mosquitoes is more common than
expected [66, 67]. This offers an unprecedented opportunity
to further studies the diversity of anopheline Wolbachia
strains to identify suitable phenotypes naturally impeding
the development of Plasmodium parasites in mosquitoes,
especially among Wolbachia strains associated with non-
malaria vectors.
4. Conclusions and Future Directions
This review discussed the current state of knowledge about
the association between mosquitoes and Wolbachia, empha-
sizing the limitation of different mosquito control strategies
and the use of mosquitoes’ commensal/introduced micro-
biota as innovative VC intervention against mosquito-borne
diseases.
In summary,
(1) Several human, animal and zoonotic diseases are
transmitted by mosquitoes of the Anopheles, Aedes,
and Culex genera. Insecticide-based vector control
tools/strategies are keys components in the fight
against major mosquito-borne diseases.
(2) The increasing emergence/ resurgence of mosquito-
borne diseases such as malaria, yellow fever, dengue,
chikungunya, and Zika fevers, and the spread of drug
resistant parasites and insecticide resistant mosquito
strains threatens the sustainability of current control
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methods and stresses the urgent need for the devel-
opment of additional control methods for mosquito-
borne diseases.
(3) Wolbachia is one of the most promising mosquito
symbionts for innovative vector control approaches.
Wolbachia has several characteristics which can be
used in such a strategy to reduce host fitness and
competes or kills the pathogens.
(4) Wolbachia was first discovered in 1924 and described
in 1936 by Marshall Hertig and S. Burt Wolbach
in the reproductive organs of Culex pipiens. The
“pandemic” nature of Wolbachia results from their
ability to manipulate host reproduction and to move
horizontally across species’ boundaries.
(5) About 31.4% of mosquito species naturally harbour
one or several Wolbachia strains. Moreover, it is now
possible to stably transinfect mosquito vector species
of medical and veterinary importance with nonnative
Wolbachia strains which can shorten vector lifespan,
limit susceptibility to infection, or induce cytoplasmic
incompatibility to reduce vector density.
(6) Wolbachia-based approach is certainly a promising
innovative strategy formosquito vector control.How-
ever, our knowledge ofWolbachia-mediated antipara-
site mechanisms is fragmented if not entirely lacking.
(7) Additional studies, including laboratory experiments,
semifield, and field trial on several mosquito vector
species in different geographical population urgently
need to be reinforced to better understandWolbachia-
mediated antiparasite mechanisms and interaction
betweenhosts and parasites but also to provide empir-
ical data to test theoretical models for Wolbachia
population dynamics, and demonstrate the feasibil-
ity and sustainability of Wolbachia-based approach
approaches to control mosquito and diseases they
transmit.
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